Audit 42932

FY End
2022-12-31
Total Expended
$25.96M
Findings
0
Programs
33
Organization: Institute for Systems Biology (WA)
Year: 2022 Accepted: 2023-06-29
Auditor: Clark Nuber P S

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.RD Cancer Genomics Cloud Resource $1.31M Yes 0
93.394 Cancer Detection and Diagnosis Research $1.11M Yes 0
93.172 Human Genome Research $985,094 Yes 0
81.RD Experimental Design, Implementation $666,376 Yes 0
93.353 21st Century Cures Act - Beau Biden Cancer Moonshot $510,135 Yes 0
93.350 National Center for Advancing Translational Sciences $427,288 Yes 0
12.431 Basic Scientific Research $357,293 Yes 0
12.420 Military Medical Research and Development $297,877 Yes 0
47.074 Biological Sciences $257,983 Yes 0
93.397 Cancer Centers Support Grants $238,712 Yes 0
93.RD Systems Biology of Influenza Virus Infection and Vaccination $186,471 Yes 0
47.083 Integrative Activities $172,903 Yes 0
93.310 Trans-Nih Research Support $121,678 Yes 0
47.050 Geosciences $103,739 Yes 0
93.865 Child Health and Human Development Extramural Research $95,416 Yes 0
93.837 Cardiovascular Diseases Research $93,741 Yes 0
93.393 Cancer Cause and Prevention Research $79,293 Yes 0
93.398 Cancer Research Manpower $74,616 Yes 0
93.855 Allergy, Immunology and Transplantation Research $61,120 Yes 0
81.049 Office of Science Financial Assistance Program $46,057 Yes 0
93.396 Cancer Biology Research $38,835 Yes 0
93.859 Biomedical Research and Research Training $25,554 Yes 0
12.RD High Throughput Platform $25,000 Yes 0
47.078 Polar Programs $24,055 Yes 0
93.838 Lung Diseases Research $18,567 Yes 0
93.866 Aging Research $17,735 Yes 0
12.RD Global Proteomic Analysis $15,973 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $10,676 Yes 0
93.839 Blood Diseases and Resources Research $6,284 Yes 0
12.RD Advancing Precision Psychiatry- $4,122 Yes 0
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $4,022 Yes 0
12.RD Inflammatory Mediators Testing $99 Yes 0
93.360 Biomedical Advanced Research and Development Authority (barda), Biodefense Medical Countermeasure Development $-1,292 Yes 0

Contacts

Name Title Type
SMK9PCMKXED6 Gary Streicher Auditee
2067321227 Vincent Stevens Auditor
No contacts on file

Notes to SEFA

Accounting Policies: Note 1 - Method of Accounting The accompanying schedule of expenditures of federal awards (the "Schedule") includes the federal award activity of the Institute for Systems Biology (the Institute) under programs of the federal government for the year ended December 31, 2022. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of the Institute, it is not intended to and does not present the financial position, changes in net assets or cash flows of the Institute. Note 2 - Significant Accounting Policies Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. The Institute has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate.